Role of Curcumin (TURMERIC) in Managing Inflammation in Cancer Patients: A Review

Author(s)	Dr. Swathi A S
Country	India
Abstract	Cancer-associated inflammation is increasingly recognized as a key contributor to tumor initiation, progression, metastasis, and treatment-related complications. Chronic inflammatory processes stimulate cellular proliferation, angiogenesis, and resistance to apoptosis, thereby creating a favourable environment for cancer progression. Curcumin, the principal bioactive constituent of turmeric (Curcuma longa), has attracted considerable attention due to its anti-inflammatory, antioxidant, and immunomodulatory properties. Several preclinical and clinical studies suggest that curcumin may modulate inflammatory pathways involved in cancer development and treatment-induced toxicity. This review summarizes current evidence regarding the role of curcumin in managing inflammation among cancer patients, its mechanisms of action, therapeutic potential, limitations, and future research directions. Available evidence indicates that curcumin may serve as a useful adjunct to conventional cancer therapies in reducing inflammatory burden and improving patient well-being.
Keywords	Curcumin, Turmeric, Cancer, Inflammation, Cytokines, Integrative Oncology, Nutraceuticals
Field	Biology
Published In	Volume 8, Issue 3, May-June 2026
Published On	2026-06-12

About IJFMR Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics Peer Review & Plagiarism	Join as a Reviewer Editors & Reviewers Reviewer Referral Program Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us		+91-9687-828-838	editor@ijfmr.com

International Journal For Multidisciplinary Research